MIA News Archives

Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.

Study reviews psychological interventions for antidepressant discontinuation.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

Study examines racial and ethnic disparities in the quality of care for Medicaid-enrolled children starting ADHD medication.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

A new study reported on in Medscape, examined risk factors for misuse of benzodiazepines (drugs such as Xanax, Ativan, and Klonopin). The researchers found that patients who had been prescribed the medication on an as-needed basis were more likely to end up abusing it than those who had been prescribed a standing dose.

A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....

Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...

A new study to be published in the next issue of Schizophrenia Research examines patients suffering from a first-episode of psychosis who stop taking any antipsychotic drugs. The researchers attempt to identify variables that can serve as predictors of the successful discontinuation of antipsychotics. They find, for example, that those who discontinue the drugs have, on average, the same outcomes as those who stay on them, and that those who have better social integration are more likely to discontinue without relapse.

Last year the British Medical Association (BMA) released a report on dependence and withdrawal from prescription drugs including benzodiazepines, z-drugs, opioids, and antidepressants. Now,...